DUPILUMAB MONOTHERAPY PROVIDES 1-YEAR SUSTAINED RESPONSE AND REDUCES NEED FOR CONCOMITANT TOPICAL STEROIDS IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS OPTIMALLY RESPONDING AT WEEK 16
ACTA DERMATO-VENEREOLOGICA（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要